During mitosis, it is involved in the regulation of the dynamic localization of cells, and studies have suggested that CDCA8 can be used as a biomarker for the early diagnosis and prognosis prediction of HCC patients. This evidence concerns the gene CDCA8 and hepatocellular carcinoma.